EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Epigenetic Regulation of the Epstein–Barr Virus Latent–Lytic Switch

Rui Guo, Benjamin E Gewurz

Journal of Medical Virology · 2026

DOI: 10.1002/jmv.71031 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Medical Virology, 2026. Verfasst von Rui Guo und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Herpesvirus 4, Human, Virus Latency, Epigenesis, Genetic, Virus Activation. Die Arbeit nennt 82 Literaturangaben. Gefördert von: NCI NIH HHS, National Institute of Allergy and Infectious Diseases, NIDCR NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epstein–Barr virus (EBV) establishes lifelong latency in humans, yet sporadically reactivates into a productive lytic cycle that enables viral propagation. The lytic phase is critical for sustaining life‐long persistence and also contributes to oncogenesis by fostering cellular environments that support EBV‐associated malignancies. EBV lytic reactivation has long been understood as a complex process shaped by the integration of multiple, largely host‐derived signals. Recent advances in genome‐wide CRISPR screening, single‐cell transcriptomics, and integrative multi‐omic analyses have substantially expanded this framework, adding rich and unexpected molecular detail to how epigenetic repression, transcriptional control, metabolic adaptation, and immune–microenvironmental cues converge to regulate the latent–lytic transition. This review synthesizes recent discoveries that refine our understanding of the molecular logic of EBV reactivation and discusses how these insights are shaping new therapeutic approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Herpesvirus 4, HumanVirus LatencyEpigenesis, GeneticVirus ActivationEpstein-Barr Virus InfectionsGene Expression Regulation, ViralHumansHost-Pathogen Interactions

Autor:innen und Institutionen

  • Department of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts, USA.
  • Department of Medicine, Division of Infectious Diseases, Mass General Brigham Hospital, Boston, Massachusetts, USA.
  • Center for Integrated Solutions in Infectious Disease, Broad Institute, Cambridge, Massachusetts, USA.
  • Department of Microbiology, Harvard Medical School, Boston, Massachusetts, USA.

Förderung

  • NCI NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • NIDCR NIH HHS
  • National Institute of Dental and Craniofacial Research
  • National Cancer Institute

Zitieren

APA

Guo, R., & Gewurz, B. E. (2026). Epigenetic Regulation of the Epstein–Barr Virus Latent–Lytic Switch. Journal of Medical Virology. https://doi.org/10.1002/jmv.71031

Vancouver

Guo R, Gewurz BE. Epigenetic Regulation of the Epstein–Barr Virus Latent–Lytic Switch. Journal of Medical Virology. 2026. doi:10.1002/jmv.71031

BibTeX
@article{Guo2026,
  author = {Guo, Rui and Gewurz, Benjamin E},
  title = {Epigenetic Regulation of the Epstein–Barr Virus Latent–Lytic Switch},
  journal = {Journal of Medical Virology},
  year = {2026},
  doi = {10.1002/jmv.71031}
}
Kostenlos starten →